These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Potentially useful markers for desmoplastic melanoma: an analysis of KBA.62, p-AKT, and ezrin.
    Author: Bernaba BN, Vogiatzis PI, Binder SW, Cassarino DS.
    Journal: Am J Dermatopathol; 2011 Jun; 33(4):333-7; quiz 338-40. PubMed ID: 21610456.
    Abstract:
    Desmoplastic melanoma (DM) represents only a small portion of newly diagnosed melanoma cases but can be a significant diagnostic challenge for dermatopathologists. Immunohistochemical stains are often useful to confirm the diagnosis; however, DM is notorious for not expressing most of the melanocytic markers other than S100. Recent studies have suggested several new markers, which may be promising in the diagnosis of DM. KBA.62 is a relatively new antimelanoma monoclonal antibody, which has not been well characterized in DM. Ezrin and p-Akt are additional markers, which have been shown to be involved in cell survival and proliferation. We collected 12 cases of DM and 18 cases of other lesions that could be included in the differential diagnosis. The H&E sections were reviewed, and immunohistochemical stains for KBA.62, p-AKT, and Ezrin were performed. Seventy-five percent of the DM cases (9 of 12) demonstrated positive staining (>5% of tumor cells staining) with KBA.62, with an average of 39% of cells staining. One hundred percent of the DM cases (12 of 12) demonstrated positive staining with Ezrin, with an average of 49% of tumor cells staining. Seventy-five percent of the DM cases (9 of 12) demonstrated positive staining with p-Akt, with an average of 49% of cells staining. KBA.62 and Ezrin demonstrated statistically significant increased staining of DM cases compared with the other lesions (P = 0.05 and P = 0.007, respectively), although it was not useful in distinguishing DM versus malignant peripheral nerve sheath tumor, whereas p-Akt showed no significant differences in staining between DM and the other cases. These findings suggest that KBA.62 may be a useful marker in confirming the diagnosis of DM.
    [Abstract] [Full Text] [Related] [New Search]